Nocturna Therapeutics

Spain
Barcelona, Catalonia, Spain, 08018

Company profile

Nocturna Therapeutics company profile

NoctuRNA Therapeutics is a biotech dedicated to developing novel and patented circular RNA-based therapies aimed at treating incurable diseases. Our focus spans infectious diseases such as Covid, Dengue, West Nile Virus and Hepatitis, as well as neuromuscular and neurodegenerative diseases that share common therapeutic targets. We are committed to pioneering innovative approaches to address significant unmet medical needs.

Business identity

Contact email
[email protected]
Phone number
0034649690721
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2022-12-16

Headquarters

Postal code
08018
Country code
ES
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$711,946
Last funding
Pre Seed / $711,946 / 2023-01-10
Last equity funding
Pre Seed / $711,946
Founders
5

Founders and investors

Founders

Amadis PagesIvan DotuJuana DíezMarc TallóMiriam Corredor